(TALK) Talkspace - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US87427V1035
TALK: Online, Therapy, Psychiatry, Mental, Health, Counseling, Telemedicine
Talkspace, Inc. is a pioneering virtual behavioral healthcare company that bridges the gap between individuals seeking mental health support and licensed professionals. By leveraging a cutting-edge online platform, the company delivers personalized psychotherapy and psychiatry services, catering to a wide range of mental health needs, including depression, anxiety, and trauma. This innovative approach enables seamless interactions through messaging, audio, and video channels, providing a comfortable and accessible environment for users.
The companys business model is diversified, serving various customer segments, including health insurance plans, employee assistance programs, direct-to-enterprise customers, and individual subscribers. This multi-channel approach allows Talkspace to tap into the growing demand for digital mental health services, driven by increasing awareness and reduced stigma around mental health issues. With its headquarters in New York, the company has established itself as a leader in the virtual behavioral healthcare space since its inception in 2012.
Analyzing the available
Based on the available data, a forecast for Talkspaces stock can be constructed. Given the companys strong positioning in the growing virtual behavioral healthcare market, coupled with its diversified business model, we can expect a potential upward trajectory. The high P/E ratio and Forward P/E suggest that the market anticipates significant earnings growth. If the company can meet or exceed these expectations, the stock price may continue to rise, potentially targeting the 52-week high of $4.17. However, if the company fails to deliver on its growth promises, the stock price may experience a correction, potentially falling back towards the 200-day SMA of $2.76. A key level to watch is the $3.04 price point, as a break above or below this level may indicate the direction of the next significant move.
Additional Sources for TALK Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TALK Stock Overview
Market Cap in USD | 534m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2020-07-30 |
TALK Stock Ratings
Growth Rating | -36.6 |
Fundamental | 12.5 |
Dividend Rating | 0.0 |
Rel. Strength | 19.1 |
Analysts | 4.67/5 |
Fair Price Momentum | 2.56 USD |
Fair Price DCF | 0.92 USD |
TALK Dividends
No Dividends PaidTALK Growth Ratios
Growth Correlation 3m | -21.7% |
Growth Correlation 12m | 55.4% |
Growth Correlation 5y | -34.1% |
CAGR 5y | -22.23% |
CAGR/Max DD 5y | -0.23 |
Sharpe Ratio 12m | -0.07 |
Alpha | 3.25 |
Beta | 1.060 |
Volatility | 73.98% |
Current Volume | 1272.3k |
Average Volume 20d | 1258.3k |
As of May 09, 2025, the stock is trading at USD 3.04 with a total of 1,272,287 shares traded.
Over the past week, the price has changed by -2.88%, over one month by +11.76%, over three months by -25.85% and over the past year by +14.29%.
Neither. Based on ValueRay Fundamental Analyses, Talkspace is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.45 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TALK as of May 2025 is 2.56. This means that TALK is currently overvalued and has a potential downside of -15.79%.
Talkspace has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy TALK.
- Strong Buy: 5
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, TALK Talkspace will be worth about 2.9 in May 2026. The stock is currently trading at 3.04. This means that the stock has a potential downside of -4.28%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5 | 64.5% |
Analysts Target Price | 4.9 | 60.5% |
ValueRay Target Price | 2.9 | -4.3% |